Division of Biological Sciences Logo

Stephen Sprang ( edit )

Professor

Contact Stephen Sprang

Phone: 406-243-6028
E-mail Address: stephen.sprang@mso.umt.edu
Office : Isb 207a

Education

 B.S. in Biochemistry from California State University of Los Angeles in 1971
Ph.D. in Biochemistry from the University of Wisconsin, Madison in 1977
Postdoctoral studies with Robert Fletterick at the University of Alberta and the University of California at San Francisco, 1978-1983

Research Interests


We study the structural chemistry of signal transduction, particularly as mediated by heterotrimeric G proteins. Experimental approaches include x-ray crystallography, enzymology and spectroscopy. We also use Molecular Dynamics simulations to better understand the conformational changes that occur in G proteins and their effectors.  The following is a brief summary of ongoing research projects. Names of Lab members are italicized; for more information, see the links to their publications in the narrative below.
What is the mechanism by which GTP hydrolysis is coupled to conformational transitions in G proteins?
It is this chemical process that is linked to the termination of signaling activity. Earlier work in the lab focused on structural studies of relevant conformational states of G protein a subunits in the GTP, GDP•Pi and GDP•AlF4--bound forms of the enzyme. More recent work has focused on structural and mutational analysis of a subunits with interesting catalytic properties and  18O kinetic isotope experiments to characterize the chemical structure of the transition state for GTP hydrolysis in various members of the G protein superfamily. 
How do G proteins regulate effectors - how do effectors regulate G proteins?
When bound to GTP, G proteins regulate the activity of signaling molecules called effectors. Effectors may have reciprocal effects on G proteins, most commonly by accelerating GTP hydrolysis (thereby leading to dissociation of the G protein from its effector). Earlier work addressed the regulation of adenylyl cyclase by Gas,
and more recently, the mechanism by which Ga13 regulates G-protein dependent regulators of cytoskeleton formation. These remarkable effectors activate the small G protein, Rho.  At the same time, these effectors deactivate Ga13, resulting in tightly coupled cycles of G-protein activation and deactivation.
How are Ga proteins activated? How is activation prevented?
 
Just as the signaling activity of G protein a subunits is terminated by GTP hydrolysis, it is initiated by GTP binding. GDP dissociation is the kinetic barrier to this process. Our laboratory has studied the mechanism by which GDP dissociation is inhibited by G protein bg heterodimers,  and by the cytosolic, GoLoco-motif containing protein AGS3,  Efforts are also underway to determine the structure of the cytosolic exchange factor, RIC-8, in complex with various G protein a subunits.  

Publications

Mou, T.C., Gille, A., Fancy, DA, Seifert, R and Sprang, S.R.,  (2005) “Structural basis for the inhibition of mammalian adenylyl cyclase by 2’(3’)-O-(N-methylanthraniolyl)-guanosine 5’-triphosphate”  Journal of Biololgical Chemistry, 280:7253-61

 Chen, Z., Singer, W.D., Sternweis, P.C. and Sprang, S. R. “Structure of the p115rhoGEF rgRGS domain of-Ga1/i1 chimera complex suggests convergent evolution of a GTPase activator “ (2005), Nature Structural and Molecular Biology, 12:191-7
 
Sinha, S.C., Wetter, M., Schultz, Sprang, S. and Linder, J (2005) “Asymmetry in Homodimeric Adenylyl Cyclases: Structures of the Mycobacterium  tuberculosis Rv 1900c”  EMBO Journal, 24:663-73
 
Davis, T.,  Bonacci, T.M., Smrcka, AV. and Sprang, S.R. (2005) “Structural and Molecular Characterization  of a Preferred Protein Interaction Surface on G Protein bg Subunits” (2005) Biochemistry 44:10593-10604
 
 Ja, W.W., Adhikari, A., Austin, R.J., Sprang, S.R., Roberts, R.W.(2005) “A peptide core motif for binding to heterotrimeric G protein a subunits”  Journal of Biological Chemistry, 280:32057-32060
 
Mou, T-C, Gille, A., Suryanarayana, S.,Richter, M., Seifert, R. and Sprang, S.R.(2006) “Broad Specificity of Mammalian Adenylyl Cyclases for Interaction with 2’,3’-Substituted Purine-and Pyrimidine Nucleotide Inhibitors”  Molecular Pharmacology,70:878-886
 
Sinha, S.C. and Sprang, S. (2006) “Structures, mechanism, regulation and evolution of class III nucleotidyl cyclases” Reviews of Physiology, Biochemistry and Pharmacology 157:105-140
 
Sprang, S.R., Chen, Z and Du, X. (2007)“Structural basis of effector regulation and signal termination in heterotrimeric Ga proteins” Advances Prot. Chem. 74:1-65
Du, X., Ferguson, K., Gregory, R. and Sprang, S.R. (2008) “A method to determine 18O kinetic isotope effects in the hydrolysis of nucleotide triphosphates” Analytical Biochemistry 372:213-21
 
Sprang, S. (2007) “A Receptor Unlocked”, Nature, 450, 355-6

Field of Study

Structural Biology and Biochemistry: Biological Signal Transduction